New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Monoclonal antibody cliramitug shows sustained benefit in cardiac amyloidosis over 29 months
Long-term follow-up of the NI006-101 trial shows that cliramitug, a monoclonal antibody targeting misfolded transthyretin, sustains clinical benefit in cardiac…
Editor's Top Picks
AI-Assisted Clinical Decision Support Shows No Benefit Over Standard Care in Kenyan Primary Care Study
A pragmatic cluster-randomized trial in Kenya found that ChatGPT-4o-assisted clinical decision support did not significantly reduce treatment failure rates in…
Submit Your Paper →
More form New Studies
Heart Shows Aging Signs by Age 40, While Brain Remains Resilient Until 60s, Cell Study Reveals
New Cell study reveals heart and kidneys show aging by age 40, while brain remains…
Gut’s 7-Meter Assembly Line Maps Nutrient Absorption with Molecular Precision
The human gastrointestinal tract functions as a 7-meter specialized assembly line, with each segment precisely…
Why Creatine Works Differently in Muscle and Brain: New Research Reveals Transport Barriers
Three decades of research reveals creatine supplements increase muscle creatine by up to 40% but…
Multivitamin supplements show clear benefits for cognitive function and pregnancy outcomes
New research analyzing dozens of studies reveals significant cognitive and pregnancy benefits from daily multivitamin…
New Three-Day Creatine Loading Protocol Shows Promise in Small Trial
New three-day creatine loading protocol using pre-exercise timing shows performance improvements in small crossover trial.…